FIGEN YILDIZ: Open Payments
NPI 1821553470 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$476 in 47 payments from 6 companies in 2025. Trend: 2023 $592 · 2024 $792 · 2025 $476
Food & beverage: $476
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $326 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| MicroTransponder, Inc. | 1 | $33 |
| Novo Nordisk Inc | 1 | $25 |
| Astellas Pharma US Inc | 1 | $24 |
| Amgen Inc. | 1 | $22 |
Products named: QULIPTA, VRAYLAR, UBRELVY, Wegovy, Veozah, REPATHA, FARXIGA, AIRSUPRA.
Industry payments across PA — which companies pay providers there.
